Literature DB >> 20372830

Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review).

Hirotaka Kajihara1, Yoshihiko Yamada, Seiji Kanayama, Naoto Furukawa, Taketoshi Noguchi, Shoji Haruta, Shozo Yoshida, Toshiyuki Sado, Hidekazu Oi, Hiroshi Kobayashi.   

Abstract

Epithelial ovarian cancer (EOC) is the most common cause of gynecological cancer-related mortality. Clear cell EOC (cEOC) has a number of clinical features distinguishing it from other EOC because of frequent concurrence of endometriosis and highly chemoresistant nature resulting in a poor prognosis. Recent biochemical studies based on genome-wide expression analysis technology have noted specific expression of a transcription factor, hepatocyte nuclear factor-1beta (HNF-1beta), in cEOC and genetic alteration may be involved in oxidative stress. We describe the HNF-1beta-dependent pathophysiology of cEOC and discuss its role in oxidative stress-induced carcinogenesis. A systematic search was performed in the electronic databases PubMed and ScienceDirect up to July 2009, combining the keywords, genome-wide, microarray, epithelial ovarian cancer, clear cell carcinoma, oxidative stress, and detoxification, with specific expression profiles of genes. The catalog of cEOC-specificity might be a manifestation of six essential alterations in cell physiology: oxidative stress and detoxification, proteases, signal transduction, adhesion, transcription, and metabolism. Among 54 genes highly upregulated in cEOC, 47 genes (87.0%) were associated with the redox-related genes. Several important cEOC-related genes overlap with those known to be regulated by HNF-1beta. Twenty-two (40.7%) of the 54 genes predominantly identified in cEOC were involved in downstream targets of HNF-1beta. The HNF-1beta-dependent pathway might provide new insights into regulation of glycogen synthesis, detoxification and resistance to anticancer agents. This review summarizes recent advances in the understanding of oxidative stress and antioxidant mechanisms in pathogenesis of cEOC. A redox-sensitive subset of cEOC genes linked to oxidative and detoxification pathways was identified and associated with HNF-1beta-specific downstream targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372830     DOI: 10.3892/or_00000750

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  27 in total

1.  Clinicopathological heterogeneity in ovarian clear cell adenocarcinoma: a study on individual therapy practice.

Authors:  Yuji Matsuo; Hironori Tashiro; Hiroyuki Yanai; Takuya Moriya; Hidetaka Katabuchi
Journal:  Med Mol Morphol       Date:  2014-11-15       Impact factor: 2.309

2.  Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression.

Authors:  Erina Suzuki; Sabine Kajita; Hiroyuki Takahashi; Toshihide Matsumoto; Tomoko Tsuruta; Makoto Saegusa
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

3.  Identification of multiple pathways involved in the malignant transformation of endometriosis (Review).

Authors:  Yumi Higashiura; Hirotaka Kajihara; Hiroshi Shigetomi; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2012-04-23       Impact factor: 2.967

4.  Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary.

Authors:  Hiroshi Kobayashi; Hiroshi Shigetomi; Chiharu Yoshimoto
Journal:  Oncol Lett       Date:  2015-05-26       Impact factor: 2.967

5.  The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review).

Authors:  Hiroshi Shigetomi; Akira Oonogi; Taihei Tsunemi; Yasuhito Tanase; Yoshihiko Yamada; Hirotaka Kajihara; Yoriko Yoshizawa; Naoto Furukawa; Shoji Haruta; Shozo Yoshida; Toshiyuki Sado; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

6.  Modulation of estrogenic action in clear cell carcinoma of the ovary (Review).

Authors:  Yasuhito Tanase; Yoshihiko Yamada; Hiroshi Shigetomi; Hirotaka Kajihara; Akira Oonogi; Yoriko Yoshizawa; Naoto Furukawa; Shoji Haruta; Shozo Yoshida; Toshiyuki Sado; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Exp Ther Med       Date:  2011-10-24       Impact factor: 2.447

Review 7.  Primary multiple clear cell variant urothelial carcinomas of urinary bladder: a rare case report.

Authors:  Yutao Zhang; Jun Huang; Hao Feng; Yun Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

8.  Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer.

Authors:  Naoki Kawahara; Kenji Ogawa; Mika Nagayasu; Mai Kimura; Yoshikazu Sasaki; Hiroshi Kobayashi
Journal:  Biomed Rep       Date:  2017-09-27

9.  Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma.

Authors:  Gian Franco Zannoni; Giuseppina Improta; Gaia Chiarello; Angela Pettinato; Marco Petrillo; Paolo Scollo; Giovanni Scambia; Filippo Fraggetta
Journal:  Virchows Arch       Date:  2014-06-03       Impact factor: 4.064

10.  The transcription factor Ikaros inhibits cell proliferation by downregulating ANXA4 expression in hepatocellular carcinoma.

Authors:  Yi-Yao Liu; Chao Ge; Hua Tian; Jing-Yi Jiang; Fang-Yu Zhao; Hong Li; Tao-Yang Chen; Ming Yao; Jin-Jun Li
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.